UniProt ID | MAG_HUMAN | |
---|---|---|
UniProt AC | P20916 | |
Protein Name | Myelin-associated glycoprotein | |
Gene Name | MAG | |
Organism | Homo sapiens (Human). | |
Sequence Length | 626 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein . Membrane raft . |
|
Protein Description | Adhesion molecule that mediates interactions between myelinating cells and neurons by binding to neuronal sialic acid-containing gangliosides and to the glycoproteins RTN4R and RTN4RL2 (By similarity). Not required for initial myelination, but seems to play a role in the maintenance of normal axon myelination. Protects motoneurons against apoptosis, also after injury; protection against apoptosis is probably mediated via interaction with neuronal RTN4R and RTN4RL2. Required to prevent degeneration of myelinated axons in adults; this probably depends on binding to gangliosides on the axon cell membrane (By similarity). Negative regulator of neurite outgrowth; in dorsal root ganglion neurons the inhibition is mediated primarily via binding to neuronal RTN4R or RTN4RL2 and to a lesser degree via binding to neuronal gangliosides. In cerebellar granule cells the inhibition is mediated primarily via binding to neuronal gangliosides. In sensory neurons, inhibition of neurite extension depends only partially on RTN4R, RTN4RL2 and gangliosides. Inhibits axon longitudinal growth (By similarity). Inhibits axon outgrowth by binding to RTN4R (By similarity). Preferentially binds to alpha-2,3-linked sialic acid. Binds ganglioside Gt1b (By similarity).. | |
Protein Sequence | MIFLTALPLFWIMISASRGGHWGAWMPSSISAFEGTCVSIPCRFDFPDELRPAVVHGVWYFNSPYPKNYPPVVFKSRTQVVHESFQGRSRLLGDLGLRNCTLLLSNVSPELGGKYYFRGDLGGYNQYTFSEHSVLDIVNTPNIVVPPEVVAGTEVEVSCMVPDNCPELRPELSWLGHEGLGEPAVLGRLREDEGTWVQVSLLHFVPTREANGHRLGCQASFPNTTLQFEGYASMDVKYPPVIVEMNSSVEAIEGSHVSLLCGADSNPPPLLTWMRDGTVLREAVAESLLLELEEVTPAEDGVYACLAENAYGQDNRTVGLSVMYAPWKPTVNGTMVAVEGETVSILCSTQSNPDPILTIFKEKQILSTVIYESELQLELPAVSPEDDGEYWCVAENQYGQRATAFNLSVEFAPVLLLESHCAAARDTVQCLCVVKSNPEPSVAFELPSRNVTVNESEREFVYSERSGLVLTSILTLRGQAQAPPRVICTARNLYGAKSLELPFQGAHRLMWAKIGPVGAVVAFAILIAIVCYITQTRRKKNVTESPSFSAGDNPPVLFSSDFRISGAPEKYESERRLGSERRLLGLRGEPPELDLSYSHSDLGKRPTKDSYTLTEELAEYAEIRVK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MIFLTALPLFWI ---CCEECHHHHHHH | 18.52 | 25072903 | |
15 | Phosphorylation | PLFWIMISASRGGHW HHHHHHHHCCCCCCC | 11.65 | 25072903 | |
17 | Phosphorylation | FWIMISASRGGHWGA HHHHHHCCCCCCCCC | 25.35 | 25072903 | |
29 | Phosphorylation | WGAWMPSSISAFEGT CCCCCCCCEEECCCE | 18.07 | 30631047 | |
31 | Phosphorylation | AWMPSSISAFEGTCV CCCCCCEEECCCEEE | 28.93 | 30631047 | |
36 | Phosphorylation | SISAFEGTCVSIPCR CEEECCCEEEECCCC | 11.53 | 30631047 | |
99 | N-linked_Glycosylation | LGDLGLRNCTLLLSN HHHHCCCCCEEEEEC | 28.33 | 7505568 | |
99 | N-linked_Glycosylation | LGDLGLRNCTLLLSN HHHHCCCCCEEEEEC | 28.33 | 7505568 | |
101 | O-linked_Glycosylation | DLGLRNCTLLLSNVS HHCCCCCEEEEECCC | 24.80 | 28657654 | |
106 | N-linked_Glycosylation | NCTLLLSNVSPELGG CCEEEEECCCHHHCC | 37.95 | 7505568 | |
106 | N-linked_Glycosylation | NCTLLLSNVSPELGG CCEEEEECCCHHHCC | 37.95 | 7505568 | |
223 | N-linked_Glycosylation | GCQASFPNTTLQFEG EEEEECCCCEEEEEE | 43.62 | 7505568 | |
223 | N-linked_Glycosylation | GCQASFPNTTLQFEG EEEEECCCCEEEEEE | 43.62 | 7505568 | |
246 | N-linked_Glycosylation | PPVIVEMNSSVEAIE CCEEEEECCCEEEEC | 20.02 | 7505568 | |
246 | N-linked_Glycosylation | PPVIVEMNSSVEAIE CCEEEEECCCEEEEC | 20.02 | 7505568 | |
315 | N-linked_Glycosylation | ENAYGQDNRTVGLSV ECCCCCCCCEEEEEE | 33.37 | 7505568 | |
315 | N-linked_Glycosylation | ENAYGQDNRTVGLSV ECCCCCCCCEEEEEE | 33.37 | 7505568 | |
406 | N-linked_Glycosylation | GQRATAFNLSVEFAP CCEEEEEEEEEECHH | 29.01 | 7505568 | |
406 | N-linked_Glycosylation | GQRATAFNLSVEFAP CCEEEEEEEEEECHH | 29.01 | 7505568 | |
430 | S-palmitoylation | AARDTVQCLCVVKSN HHCCEEEEEEEECCC | 2.50 | 29575903 | |
432 | S-palmitoylation | RDTVQCLCVVKSNPE CCEEEEEEEECCCCC | 4.32 | 29575903 | |
436 | Phosphorylation | QCLCVVKSNPEPSVA EEEEEECCCCCCCEE | 46.11 | - | |
441 | Phosphorylation | VKSNPEPSVAFELPS ECCCCCCCEEEECCC | 25.15 | - | |
450 | N-linked_Glycosylation | AFELPSRNVTVNESE EEECCCCCEECCHHH | 37.84 | 7505568 | |
450 | N-linked_Glycosylation | AFELPSRNVTVNESE EEECCCCCEECCHHH | 37.84 | 7505568 | |
454 | N-linked_Glycosylation | PSRNVTVNESEREFV CCCCEECCHHHHHEE | 37.40 | 7505568 | |
454 | N-linked_Glycosylation | PSRNVTVNESEREFV CCCCEECCHHHHHEE | 37.40 | 7505568 | |
531 | S-palmitoylation | AILIAIVCYITQTRR HHHHHHHHHHHHHCC | 1.34 | 1703542 | |
543 | Phosphorylation | TRRKKNVTESPSFSA HCCCCCCCCCCCCCC | 39.89 | 18510355 | |
545 | Phosphorylation | RKKNVTESPSFSAGD CCCCCCCCCCCCCCC | 19.24 | 25332170 | |
547 | Phosphorylation | KNVTESPSFSAGDNP CCCCCCCCCCCCCCC | 40.90 | 18510355 | |
549 | Phosphorylation | VTESPSFSAGDNPPV CCCCCCCCCCCCCCE | 35.36 | 24076635 | |
571 | Phosphorylation | ISGAPEKYESERRLG ECCCCHHHHHHHHHC | 24.03 | - | |
575 | Methylation | PEKYESERRLGSERR CHHHHHHHHHCCCHH | 48.69 | 54487783 | |
620 | Phosphorylation | LTEELAEYAEIRVK- CHHHHHHHHHHEEC- | 12.15 | 7525550 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MAG_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MAG_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MAG_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CO1A1_HUMAN | COL1A1 | physical | 2446864 | |
CO2A1_HUMAN | COL2A1 | physical | 2446864 | |
CO3A1_HUMAN | COL3A1 | physical | 2446864 | |
CO4A1_HUMAN | COL4A1 | physical | 2446864 | |
CO5A1_HUMAN | COL5A1 | physical | 2446864 | |
CO6A1_HUMAN | COL6A1 | physical | 2446864 | |
CO9A1_HUMAN | COL9A1 | physical | 2446864 | |
FYN_HUMAN | FYN | physical | 7525550 | |
MAP1B_HUMAN | MAP1B | physical | 11733546 | |
A4_HUMAN | APP | physical | 21832049 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Identification of the glycosylated sequons of human myelin-associatedglycoprotein."; Burger D., Pidoux L., Steck A.J.; Biochem. Biophys. Res. Commun. 197:457-464(1993). Cited for: GLYCOSYLATION AT ASN-99; ASN-106; ASN-223; ASN-246; ASN-315; ASN-406;ASN-450 AND ASN-454, AND LACK OF GLYCOSYLATION AT ASN-332. |